Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Ex vivo reversal of dabigatran and rivaroxaban anticoagulation in healthy male volunteers
2010-022846-26Phase 4Active
- Sponsor
- CHU Grenoble Alpes
- Start
- Sep 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of rivaroxaban and dabigatran (2 cohorts), sponsored by CHU Grenoble Alpes. Started Sep 2010; status: active.
02
Drugs
rivaroxabandabigatran
Beyond the preview
Go deeper on 2010-022846-26.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2010-022846-26.